Schedule 13G filing

Darwin Global Management, Ltd. disclosed a 5.9% stake in Genmab A/S (GMAB)

Schedule 13G · Filed Oct 6, 2026

Darwin Global Management, Ltd. reported owning 5.9% of Genmab A/S (GMAB) (3,668,310 shares) in a Schedule 13G filed Oct 6, 2026.

A 13G is a passive stake: the holder does not plan to push for changes.

Stake

Genmab A/S

Stake

5.9% stake

Share this trade

From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.